Matches in DBpedia 2014 for { <http://dbpedia.org/resource/ZIOPHARM_Oncology> ?p ?o. }
Showing items 1 to 38 of
38
with 100 items per page.
- ZIOPHARM_Oncology abstract "ZIOPHARM Oncology is an American biopharmaceutical company headquartered in Boston, Massachusetts, that develops novel therapeutics for the treatment of cancer.ZIOPHARM has three oncology therapeutics in clinical development: IL-12 DNA, indibulin (ZIO-301) and darinaparsin (ZIO-101). In 2011, ZIOPHARM established a partnership with Intrexon Corporation to develop and commercialize DNA therapeutics based on Intrexon's synthetic biology technology platform. The exclusive channel partnership between Intrexon and ZIOPHARM has been established specifically for the field of human oncologic therapeutics. Under the partnership, ZIOPHARM will be responsible for conducting preclinical and clinical development of candidates, as well as for other aspects of manufacturing and the commercialization of the candidates.".
- ZIOPHARM_Oncology industry Biotechnology.
- ZIOPHARM_Oncology keyPerson General_counsel.
- ZIOPHARM_Oncology keyPerson Jonathan_Lewis_(oncologist).
- ZIOPHARM_Oncology location Boston.
- ZIOPHARM_Oncology location New_York_City.
- ZIOPHARM_Oncology type Public_company.
- ZIOPHARM_Oncology wikiPageExternalLink www.intrexon.com.
- ZIOPHARM_Oncology wikiPageExternalLink www.ziopharm.com.
- ZIOPHARM_Oncology wikiPageID "35759528".
- ZIOPHARM_Oncology wikiPageRevisionID "570280215".
- ZIOPHARM_Oncology companyLogo "ZIOPHARM_Logo.png".
- ZIOPHARM_Oncology companyName "ZIOPHARM Oncology, Inc.".
- ZIOPHARM_Oncology companyType Public_company.
- ZIOPHARM_Oncology hasPhotoCollection ZIOPHARM_Oncology.
- ZIOPHARM_Oncology homepage www.ziopharm.com.
- ZIOPHARM_Oncology industry Biotechnology.
- ZIOPHARM_Oncology keyPeople "Caesar Belbel".
- ZIOPHARM_Oncology keyPeople "Jonathan Lewis".
- ZIOPHARM_Oncology location Boston.
- ZIOPHARM_Oncology location New_York_City.
- ZIOPHARM_Oncology subject Category:Biotechnology_companies_of_the_United_States.
- ZIOPHARM_Oncology type Agent.
- ZIOPHARM_Oncology type Company.
- ZIOPHARM_Oncology type Organisation.
- ZIOPHARM_Oncology type Organization.
- ZIOPHARM_Oncology type Agent.
- ZIOPHARM_Oncology type SocialPerson.
- ZIOPHARM_Oncology type Thing.
- ZIOPHARM_Oncology comment "ZIOPHARM Oncology is an American biopharmaceutical company headquartered in Boston, Massachusetts, that develops novel therapeutics for the treatment of cancer.ZIOPHARM has three oncology therapeutics in clinical development: IL-12 DNA, indibulin (ZIO-301) and darinaparsin (ZIO-101). In 2011, ZIOPHARM established a partnership with Intrexon Corporation to develop and commercialize DNA therapeutics based on Intrexon's synthetic biology technology platform.".
- ZIOPHARM_Oncology label "ZIOPHARM Oncology".
- ZIOPHARM_Oncology sameAs m.03p3kgs.
- ZIOPHARM_Oncology sameAs Q17125902.
- ZIOPHARM_Oncology sameAs Q17125902.
- ZIOPHARM_Oncology wasDerivedFrom ZIOPHARM_Oncology?oldid=570280215.
- ZIOPHARM_Oncology homepage www.ziopharm.com.
- ZIOPHARM_Oncology isPrimaryTopicOf ZIOPHARM_Oncology.
- ZIOPHARM_Oncology name "ZIOPHARM Oncology, Inc.".